CN104258275A - Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis - Google Patents

Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis Download PDF

Info

Publication number
CN104258275A
CN104258275A CN201410488352.6A CN201410488352A CN104258275A CN 104258275 A CN104258275 A CN 104258275A CN 201410488352 A CN201410488352 A CN 201410488352A CN 104258275 A CN104258275 A CN 104258275A
Authority
CN
China
Prior art keywords
parts
rhizoma
blood stasis
ovarian tumor
chinese medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410488352.6A
Other languages
Chinese (zh)
Inventor
杨建平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410488352.6A priority Critical patent/CN104258275A/en
Publication of CN104258275A publication Critical patent/CN104258275A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/89Cyperaceae (Sedge family)
    • A61K36/8905Cyperus (flatsedge)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/24Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/62Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02Algae
    • A61K36/03Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536Prunella or Brunella (selfheal)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/58Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/66Papaveraceae (Poppy family), e.g. bloodroot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966Fritillaria, e.g. checker lily or mission bells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/902Sparganiaceae (Bur-reed family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicinal composition for treating benign ovarian tumor with a syndrome of internal blood stasis. The traditional Chinese medicinal composition is prepared from the following medicines: rhizoma cyperi, root of three-nerved spicebush, szechwan chinaberry fruit, trogopterus dung, angelica, fructus aurantii, rhizoma corydalis, leech, ground beetle, rhizoma sparganii, curcuma zedoary, safflower, marmor serpentinatum, oyster, selfheal, fritillaria cirrhosa, seaweed, kelp and bryozoatum; and the traditional Chinese medicinal composition is prepared into any one common oral preparation (decoction, pill or capsule) through a conventional traditional Chinese medicinal preparation method.

Description

A kind of Chinese medicine composition being used for the treatment of junction type benign ovarian tumor in blood stasis
Technical field:
The invention belongs to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine composition being used for the treatment of junction type benign ovarian tumor in blood stasis.
Background technology:
Ovarian tumor can betide any age, but is more common in women at fertile age, is the most kinds of tumor of gynecological, accounts for 1/3rd of female genital organ tumor.Clinical manifestation is that less lump does not generally produce symptom, occasionally has Ipsilateral lower abdomen to sink and falls or lead sensation bitterly.Can know and touch abdominal mass, smooth surface, without tenderness, have cystic sense.Most benign tumor forms a longer handle base of a fruit with fallopian tube, and because tumor and surrounding tissue are many without adhesion, therefore mobility is comparatively greatly, often can by lump from the passing of lower abdomen side to epigastrium.Malignant growth is rapid, and how irregular lump is, Immobility, can accompany ascites, occurs that General Symptoms is as weak, heating, inappetence etc. in a short time.Functional ovarian tumor, as granulosa cell tumor, because producing a large amount of estrogen, can cause the symptom of sexual precosity.As physique, mammary gland, the equal blastoprolepsis of external genitalia, and there is menstruation in femaleness, but does not ovulate.Skeleton development can surmount normal range.In urine, estrogen increases, and in urine, promoting sexual gland hormone also raises simultaneously, exceeds universal law and reaches adult levels.Tumor body can occur the Ovarian Tumor (comprising retention ovarian cyst) of median size, the base of a fruit head and the base of a fruit is reversed.Once reverse, can occur hemorrhage and downright bad, clinical signs is acute abdomen, and infant can have stomachache, n or V, tumor locus tension of abdominal muscle during inspection, and tenderness is obvious, and infant can have body temperature to raise and leukocytosis.When tumor is larger, compressing adjacent organs, can cause and urinate and difficult defecation.
In clinical treatment blood stasis, junction type benign ovarian tumor is comparatively thorny, and oral class medicine or the Ramulus Cinnamomi Poria pill class Chinese patent medicine of invigorating blood circulation of general treatment, cures the symptoms, not the disease, do not reach the object for the treatment of.
Summary of the invention:
Technical scheme of the present invention there is provided a kind of Chinese medicine composition for the treatment of junction type benign ovarian tumor in blood stasis, is be that raw material is prepared from by the Chinese medicine of following weight proportion:
Rhizoma Cyperi 6-12 part, Radix Linderae 6-12 part, Fructus Toosendan 6-12 part, Oletum Trogopterori 6-12 part, Radix Angelicae Sinensis 9-15 part, Fructus Aurantii 9-15 part, Rhizoma Corydalis 6-12 part, Hirudo 3-9 part, eupolyphaga 6-12 part, Rhizoma Sparganii 6-12 part, Rhizoma Curcumae 6-12 part, Flos Carthami 3-9 part, Ophicalcitum 9-15 part, Concha Ostreae 12-18 part, Spica Prunellae 12-18 part, Bulbus Fritillariae Cirrhosae 6-12 part, Sargassum 9-15 part, Thallus Laminariae (Thallus Eckloniae) 9-15 part, Pumex 9-15 part, every part be 1 gram.
The optimum weight proportioning of technical solution of the present invention is:
Rhizoma Cyperi 9 parts, the Radix Linderae 9 parts, Fructus Toosendan 9 parts, Oletum Trogopterori 9 parts, Radix Angelicae Sinensis 12 parts, Fructus Aurantii 12 parts, Rhizoma Corydalis 9 parts, Hirudo 6 parts, eupolyphaga 9 parts, Rhizoma Sparganii 9 parts, Rhizoma Curcumae 9 parts, 6 parts, Flos Carthami, Ophicalcitum 12 parts, Concha Ostreae 15 parts, Spica Prunellae 15 parts, Bulbus Fritillariae Cirrhosae 9 parts, Sargassum 12 parts, Thallus Laminariae (Thallus Eckloniae) 12 parts, Pumex 12 parts, every part are 1 gram.
The present invention is a kind of instant effect, good effect, Chinese drugs agentia without any side effects.
The traditional Chinese medical science is thought: in treatment blood stasis, junction type benign ovarian tumor should with circulation of qi promoting removing blood stasis with potent drugs, removing food stagnancy softening the hard mass for Therapeutic Principle.Rhizoma Cyperi, the Radix Linderae, Fructus Toosendan, Oletum Trogopterori, Radix Angelicae Sinensis, Fructus Aurantii, Rhizoma Corydalis, Hirudo, eupolyphaga circulation of qi promoting removing blood stasis with potent drugs in side; Rhizoma Sparganii, Rhizoma Curcumae, Flos Carthami, Ophicalcitum, Concha Ostreae, Spica Prunellae, Bulbus Fritillariae Cirrhosae, Sargassum, Thallus Laminariae (Thallus Eckloniae), Pumex removing food stagnancy softening the hard mass; Said medicine compatibility uses, synergism, thus the object reaching treatment.
Detailed description of the invention:
After medicine of the present invention configures according to component, can conventionally be fried into decoction and take, also can manufacture Chinese medicine pill by conventional method and take, capsule can also be become to take according to the daily dosimetric system of Chinese herbal medicine.
For proving clinical efficacy and the safety of medicine of the present invention further.69 routine patients are selected to carry out clinical observation to medicine of the present invention.
In 100 routine patients, January is a course for the treatment of, effective 70 examples; Effective 97 examples; Invalid 2 examples; Total effective rate 97%.Whole use the present invention treats, and therapeutic outcome is in table 1.
Rear curative effect statistical result treated by table 1
Patient Number of cases Effective (%) Effectively (%) Invalid (%) Total effective rate (%)
One the course for the treatment of cured person 38 28(73.6) 38(100) 0(0) 38(100)
Two the course for the treatment of cured person 32 20(62.5) 32(100) 0(0) 32(100)
Two the course for the treatment of above cured person 30 22(73.3) 27(90) 3(10) 27(90)
Amount to 100 70(70) 97(97) 3(10) 97(97)
Criterion of therapeutical effect: effective: ultrasound diagnosis ovarian tumor transference cure; Effective: ultrasound diagnosis ovarian tumor reduces or disappears; Invalid: without significant change before and after treatment.
Therapeutic Method:
Usage and consumption: adopt the medicament prepared by the embodiment of the present invention, its usage and consumption as follows: (1) decoction: first dose adds water 700 milliliters and decoct to 200 milliliters, second dose adds water 500 milliliters and decocts to 200 milliliters, every day twice, sooner or later empty clothes; (2) capsule: every content of dispersion 0.4 gram; Every day 3 times, each 2, warm water takes; (3) pill: every 9 grams, ball.Every day 3 times, each 1 ball, warm water takes.
Embodiment (1):
Treat a Chinese medicine composition for junction type ovarian tumor in blood stasis, be made up of the raw material of following weight proportion:
Rhizoma Cyperi 9 parts, the Radix Linderae 9 parts, Fructus Toosendan 9 parts, Oletum Trogopterori 9 parts, Radix Angelicae Sinensis 12 parts, Fructus Aurantii 12 parts, Rhizoma Corydalis 9 parts, Hirudo 6 parts, eupolyphaga 9 parts, Rhizoma Sparganii 9 parts, Rhizoma Curcumae 9 parts, 6 parts, Flos Carthami, Ophicalcitum 12 parts, Concha Ostreae 15 parts, Spica Prunellae 15 parts, Bulbus Fritillariae Cirrhosae 9 parts, Sargassum 12 parts, Thallus Laminariae (Thallus Eckloniae) 12 parts, Pumex 12 parts, every part are 1 gram.
Decoct into decoction after said medicine being mixed, first dose adds water 700 milliliters and decocts to 200 milliliters, and second dose adds water 500 milliliters and decoct to 200 milliliters, every day twice, sooner or later empty clothes.
Embodiment (2):
Treat a Chinese medicine composition for junction type ovarian tumor in blood stasis, be made up of the raw material of following weight proportion:
Rhizoma Cyperi 6 parts, the Radix Linderae 6 parts, Fructus Toosendan 6 parts, Oletum Trogopterori 6 parts, Radix Angelicae Sinensis 9 parts, Fructus Aurantii 9 parts, Rhizoma Corydalis 6 parts, Hirudo 3 parts, eupolyphaga 6 parts, Rhizoma Sparganii 6 parts, Rhizoma Curcumae 6 parts, 3 parts, Flos Carthami, Ophicalcitum 9 parts, Concha Ostreae 12 parts, Spica Prunellae 12 parts, Bulbus Fritillariae Cirrhosae 6 parts, Sargassum 9 parts, Thallus Laminariae (Thallus Eckloniae) 9 parts, Pumex 9 parts, every part are 1 gram.
Both No. 0 capsule has been loaded after fine powder crosses 1500 mesh sieves, every content of dispersion 0.4 gram by being ground into after the mixing of each component of above-mentioned weight.Every day 3 times, each 2, warm water takes.
Embodiment (3):
Treat a Chinese medicine composition for junction type ovarian tumor in blood stasis, be made up of the raw material of following weight proportion:
Rhizoma Cyperi 12 parts, the Radix Linderae 12 parts, Fructus Toosendan 12 parts, Oletum Trogopterori 12 parts, Radix Angelicae Sinensis 15 parts, Fructus Aurantii 15 parts, Rhizoma Corydalis 12 parts, Hirudo 9 parts, eupolyphaga 12 parts, Rhizoma Sparganii 12 parts, Rhizoma Curcumae 12 parts, 9 parts, Flos Carthami, Ophicalcitum 15 parts, Concha Ostreae 18 parts, Spica Prunellae 18 parts, Bulbus Fritillariae Cirrhosae 12 parts, Sargassum 15 parts, Thallus Laminariae (Thallus Eckloniae) 15 parts, Pumex 15 parts, every part are 1 gram.
Pill is made, 9 grams, every ball by being ground into after fine powder crosses 1500 mesh sieves after each component mixing of above-mentioned weight.Every day 3 times, each 1 ball, warm water takes.

Claims (4)

1. being used for the treatment of a Chinese medicine composition for junction type benign ovarian tumor in blood stasis, it is characterized in that, is be made up of the medicine of following weight:
Rhizoma Cyperi 6-12 part, Radix Linderae 6-12 part, Fructus Toosendan 6-12 part, Oletum Trogopterori 6-12 part, Radix Angelicae Sinensis 9-15 part, Fructus Aurantii 9-15 part, Rhizoma Corydalis 6-12 part, Hirudo 3-9 part, eupolyphaga 6-12 part, Rhizoma Sparganii 6-12 part, Rhizoma Curcumae 6-12 part, Flos Carthami 3-9 part, Ophicalcitum 9-15 part, Concha Ostreae 12-18 part, Spica Prunellae 12-18 part, Bulbus Fritillariae Cirrhosae 6-12 part, Sargassum 9-15 part, Thallus Laminariae (Thallus Eckloniae) 9-15 part, Pumex 9-15 part, every part be 1 gram.
2. the Chinese medicine composition of junction type benign ovarian tumor in blood stasis according to claim 1, it is characterized in that, be made up of the medicine of following weight:
Rhizoma Cyperi 9 parts, the Radix Linderae 9 parts, Fructus Toosendan 9 parts, Oletum Trogopterori 9 parts, Radix Angelicae Sinensis 12 parts, Fructus Aurantii 12 parts, Rhizoma Corydalis 9 parts, Hirudo 6 parts, eupolyphaga 9 parts, Rhizoma Sparganii 9 parts, Rhizoma Curcumae 9 parts, 6 parts, Flos Carthami, Ophicalcitum 12 parts, Concha Ostreae 15 parts, Spica Prunellae 15 parts, Bulbus Fritillariae Cirrhosae 9 parts, Sargassum 12 parts, Thallus Laminariae (Thallus Eckloniae) 12 parts, Pumex 12 parts, every part are 1 gram.
3. a kind of Chinese medicine composition for the treatment of junction type benign ovarian tumor in blood stasis according to claim 1,2, is characterized in that, method of Chinese medicinal routinely can be prepared into the conventional oral formulations of any one.
4. a kind of Chinese medicine composition for the treatment of junction type benign ovarian tumor in blood stasis according to claim 3, it is characterized in that, described oral formulations is decoction, pill, capsule.
CN201410488352.6A 2014-09-14 2014-09-14 Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis Pending CN104258275A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410488352.6A CN104258275A (en) 2014-09-14 2014-09-14 Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410488352.6A CN104258275A (en) 2014-09-14 2014-09-14 Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis

Publications (1)

Publication Number Publication Date
CN104258275A true CN104258275A (en) 2015-01-07

Family

ID=52149932

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410488352.6A Pending CN104258275A (en) 2014-09-14 2014-09-14 Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis

Country Status (1)

Country Link
CN (1) CN104258275A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012866A (en) * 2015-07-03 2015-11-04 蔡涛 Externally-used traditional Chinese medicine ointment for treating gynecological disease and preparation method thereof
CN105381394A (en) * 2015-11-14 2016-03-09 薛学明 Medicine for treating benign tumors and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012866A (en) * 2015-07-03 2015-11-04 蔡涛 Externally-used traditional Chinese medicine ointment for treating gynecological disease and preparation method thereof
CN105381394A (en) * 2015-11-14 2016-03-09 薛学明 Medicine for treating benign tumors and preparation method thereof

Similar Documents

Publication Publication Date Title
CN1302801C (en) Compound traditional Chinese medicine formulation for curing hysteromyoma
CN102188685B (en) Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof
CN104027517A (en) Traditional Chinese medicine for treating acute enteritis
CN103211899A (en) Method for treating psoriasis
CN102727693B (en) Compound propolis composition used for treating swine toxoplasmosis, and preparation method thereof
CN102698085A (en) Chinese medicinal plaster for treating arthritis
CN104258275A (en) Traditional Chinese medicinal composition for treating benign ovarian tumor with syndrome of internal blood stasis
CN103083616B (en) Traditional Chinese medicine for treating ovarian cyst
CN101797308B (en) External medicine for treating mastitis
CN102973866B (en) Traditional Chinese medicine compound navel patch for treating prostate disease
CN101961455A (en) Traditional Chinese medicine for treating chronic colitis disease
CN105250961A (en) Medicine for treating hyperplasia of mammary glands
CN104324091A (en) Traditional Chinese medicine formula for treating rectal cancer
CN102961704A (en) Pharmaceutical composition for treating liver caner and method for preparing dispersible tablets thereof
CN103877471B (en) Traditional Chinese medicinal composition for treating porcine viral diarrhea and preparation method thereof
CN102988950A (en) Traditional Chinese medicine composition used for treating sexual hypoactivity
CN102935139A (en) Compound propolis composition for treating chronic gastroenteritis of livestock and preparation method of composition
CN1631386A (en) Navel plastered film for treating infantile diarrhea
CN102949537B (en) Chinese medicament for treating prostatitis
CN106138922A (en) A kind of Chinese medicine formula treating rectal cancer
CN104721638A (en) Traditional Chinese medicine preparation used for treating prostatitis
CN104547434A (en) Traditional Chinese medicine composition for treating chronic prostatitis
CN104524528A (en) Chinese herb preparation treating anemofrigid-damp arthralgia syndrome
CN104042728A (en) Traditional Chinese medicine for treating rectocele
CN104161861A (en) Traditional Chinese medicine for treating senile constipation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150107